Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 5
1979 3
1980 6
1981 6
1982 13
1983 8
1984 31
1985 37
1986 30
1987 49
1988 33
1989 45
1990 41
1991 42
1992 51
1993 58
1994 72
1995 75
1996 111
1997 123
1998 111
1999 141
2000 149
2001 181
2002 188
2003 225
2004 259
2005 282
2006 340
2007 388
2008 405
2009 407
2010 421
2011 384
2012 425
2013 417
2014 386
2015 424
2016 388
2017 328
2018 330
2019 314
2020 334
2021 228
Text availability
Article attribute
Article type
Publication date

Search Results

7,373 results
Results by year
Filters applied: . Clear all
Page 1
Escitalopram.
Aronson S, Delgado P. Aronson S, et al. Drugs Today (Barc). 2004 Feb;40(2):121-31. doi: 10.1358/dot.2004.40.2.799424. Drugs Today (Barc). 2004. PMID: 15045034 Review.
This chapter reviews preclinical and clinical studies with escitalopram, focusing on its therapeutic profile of action and tolerability. Escitalopram is the S-enantiomer of the racemic SSRI citalopram. It has been proposed that the S-enantiomer of citalopr
This chapter reviews preclinical and clinical studies with escitalopram, focusing on its therapeutic profile of action and tolerability. Esc …
Clinical pharmacology review of escitalopram for the treatment of depression.
Pastoor D, Gobburu J. Pastoor D, et al. Expert Opin Drug Metab Toxicol. 2014 Jan;10(1):121-8. doi: 10.1517/17425255.2014.863873. Epub 2013 Nov 30. Expert Opin Drug Metab Toxicol. 2014. PMID: 24289655 Review.
INTRODUCTION: Depression is a serious and debilitating psychiatric condition with serious societal health and economic implications. Escitalopram , the S-enantiomer of racemic citalopram, is an effective treatment for major depressive disorder. ...EXPERT OPINION: Dr …
INTRODUCTION: Depression is a serious and debilitating psychiatric condition with serious societal health and economic implications. Escital …
Should We be Worried About QTc Prolongation Using Citalopram? A Review.
Hutton LMJ, Cave AJ, St-Jean R, Banh HL. Hutton LMJ, et al. J Pharm Pract. 2017 Jun;30(3):353-358. doi: 10.1177/0897190015624862. Epub 2016 Jan 13. J Pharm Pract. 2017. PMID: 26763342 Review.
PURPOSE: Summarize available information regarding clinical impact of citalopram on the QTc interval. METHODS: A literature search was conducted in Pubmed, EMBASE, and Cochrane databases using the MeSH term "long QT syndrome" and key word "citalopram" on July 11, 20 …
PURPOSE: Summarize available information regarding clinical impact of citalopram on the QTc interval. METHODS: A literature search wa …
Citalopram in the treatment of depression.
Parker NG, Brown CS. Parker NG, et al. Ann Pharmacother. 2000 Jun;34(6):761-71. doi: 10.1345/aph.19137. Ann Pharmacother. 2000. PMID: 10860138 Review.
Citalopram is also the least expensive antidepressant available to date. ...CONCLUSIONS: Clinical trials demonstrate that citalopram's therapeutic efficacy is significantly greater than that of placebo and is comparable with that of other antidepressants. ...
Citalopram is also the least expensive antidepressant available to date. ...CONCLUSIONS: Clinical trials demonstrate that citalopr
[Citalopram].
El-Armouche A, Zolk O, Eschenhagen T. El-Armouche A, et al. Dtsch Med Wochenschr. 2003 Oct 24;128(43):2253-6. doi: 10.1055/s-2003-43098. Dtsch Med Wochenschr. 2003. PMID: 14574639 Review. German. No abstract available.
Citalopram and cardiac toxicity.
Cooke MJ, Waring WS. Cooke MJ, et al. Eur J Clin Pharmacol. 2013 Apr;69(4):755-60. doi: 10.1007/s00228-012-1408-1. Epub 2012 Sep 21. Eur J Clin Pharmacol. 2013. PMID: 22996077 Review.
PURPOSE: Citalopram is a selective serotonin reuptake inhibitor (SSRI) antidepressant that is widely used in clinical practice. ...The present manuscript reviews the available data concerning citalopram and cardiac toxicity. METHODS: Published data concerning the ca …
PURPOSE: Citalopram is a selective serotonin reuptake inhibitor (SSRI) antidepressant that is widely used in clinical practice. ...Th …
[Citalopram].
Taéron C. Taéron C. Rev Infirm. 2008 Nov;(145):47-9. Rev Infirm. 2008. PMID: 19044198 French. No abstract available.
[Escitalopram and citalopram: the unexpected role of the R-enantiomer].
Jacquot C, David DJ, Gardier AM, Sánchez C. Jacquot C, et al. Encephale. 2007 Mar-Apr;33(2):179-87. doi: 10.1016/s0013-7006(07)91548-1. Encephale. 2007. PMID: 17675913 Review. French.
Separating these 2 enantiomers has enabled studying their individual properties. Citalopram's pharmacologic activity is centered on the S enantiomer's high affinity for the serotonin transporter which is twice as high as citalopram's and …
Separating these 2 enantiomers has enabled studying their individual properties. Citalopram's pharmacologic activity is center …
Overview of the safety of citalopram.
Nemeroff CB. Nemeroff CB. Psychopharmacol Bull. 2003 Winter;37(1):96-121. Psychopharmacol Bull. 2003. PMID: 14561952 Review.
Citalopram is a highly selective serotonin reuptake inhibitor (SSRI) that has been prescribed to >30 million patients in >70 countries. ...Few drugs appear to interact with citalopram in a clinically meaningful way. Well-designed short- and long-term trials de
Citalopram is a highly selective serotonin reuptake inhibitor (SSRI) that has been prescribed to >30 million patients in >70 co
7,373 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page